Effect of the 5-HT1A partial agonist buspirone on regional cerebral blood flow in man

Psychopharmacology (Berl). 1992;108(3):380-6. doi: 10.1007/BF02245127.

Abstract

Repeated measurements of regional cerebral blood flow (rCBF) were made in normal volunteers before, and after, the administration of the 5-HT1A partial agonist, buspirone, or placebo. The difference in rCBF, before and after drug, (buspirone versus placebo) was used to identify brain areas affected by buspirone. Buspirone-induced changes in rCBF were studied under two behavioural conditions (5 word-list learning and 15 word-list learning). Compared to placebo, buspirone increased blood flow in the cuneus during both behavioural states. However, decreases in blood flow, centred in the left dorso-lateral prefrontal cortex and posterior cingulate cortex, were only observed under one of the two behavioural conditions. It is concluded that buspirone-induced alterations in regional cerebral blood flow are better understood, not in relation to the known distribution of monoamine neurotransmitter systems (particularly ascending 5-HT projections), but rather in relation to putative neuronal circuits possibly many synapses "downstream" of buspirone's pharmacological site of action.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Arousal / drug effects
  • Buspirone / adverse effects
  • Buspirone / blood
  • Buspirone / pharmacology*
  • Cerebrovascular Circulation / drug effects*
  • Growth Hormone / blood
  • Humans
  • Male
  • Prolactin / blood
  • Receptors, Serotonin / drug effects*
  • Stress, Psychological / blood
  • Tomography, Emission-Computed

Substances

  • Receptors, Serotonin
  • Prolactin
  • Growth Hormone
  • Buspirone